The in vivo effects of recombinant bovine herpesvirus-1 expressing bovine interferon-γ

References

1. Babiuk L. A., Bielefeldt Ohmann H., Gifford G., Czarniecki C. W., Scialli V. T., Hamilton E. B. 1985; Effect of bovine α₁ interferon on bovine herpesvirus type 1-induced respiratory disease. Journal of General Virology 66:2383–2394
   [Google Scholar]
2. Bembridge G. P., Lopez J. A., Cook R., Melero J. A., Taylor G. 1998; Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon. Journal of Virology 72:4080–4087
   [Google Scholar]
3. Bielefeldt Ohmann H., Babiuk L. A. 1985; Viral–bacterial pneumonia in calves: effect of bovine herpesvirus-1 on immunologic functions. Journal of Infectious Diseases 151:937–947
   [Google Scholar]
4. Bielefeldt Ohmann H., Gilchrist J. E., Babiuk L. A. 1984; Effect of recombinant DNA-produced bovine interferon alpha (BoIFN-α₁) on the interaction between bovine alveolar macrophages and bovine herpesvirus type 1. Journal of General Virology 65:1487–1495
   [Google Scholar]
5. Bielefeldt Ohmann H., Lawman M. J., Babiuk L. A. 1987; Bovine interferon: its biology and application in veterinary medicine. Antiviral Research 7:187–210
   [Google Scholar]
6. Boehm U., Klamp T., Groot M., Howard J. C. 1997; Cellular responses to interferon-gamma. Annual Review of Immunology 15:749–795
   [Google Scholar]
7. Campos M., Ohmann H. B., Hutchings D., Rapin N., Babiuk L. A., Lawman M. J. 1989; Role of interferon-gamma in inducing cytotoxicity of peripheral blood mononuclear leukocytes to bovine herpesvirus type 1 (BHV-1)-infected cells. Cell Immunology 120:259–269
   [Google Scholar]
8. Cerretti D. P., McKereghan K., Larsen A., Cosman D., Gillis S., Baker P. E. 1986; Cloning, sequence and expression of bovine interferon-gamma. Journal of Immunology 136:4561–4564
   [Google Scholar]
9. Chiang Y. W., Roth J. A., Andrews J. J. 1990; Influence of recombinant bovine interferon gamma and dexamethasone on pneumonia attributable to Haemophilus somnus in calves. American Journal of Veterinary Research 51:759–762
   [Google Scholar]
10. Denis M., Hanon E., Rijsewijk F. A., Kaashoek M. J., van Oirschot J. T., Thiry E., Pastoret P. P. 1996; The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1. Veterinary Microbiology 53:121–132
    [Google Scholar]
11. Fauci A. S., Pantaleo G., Stanley S., Weissman D. 1996; Immunopathogenic mechanisms of HIV infection. Annals of Internal Medicine 124:654–663
    [Google Scholar]
12. Giavedoni L. D., Jones L., Gardner M. B., Gibson H. L., Ng C. T., Barr P. J., Yilma T. 1992; Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice. Proceedings of the National Academy of Sciences, USA 89:3409–3413
    [Google Scholar]
13. Giavedoni L., Ahmad S., Jones L., Yilma T. 1997; Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. Journal of Virology 71:866–872
    [Google Scholar]
14. Griebel P. J., Qualtiere L., Davis W. C., Lawman M. J., Babiuk L. A. 1987; Bovine peripheral blood leukocyte subpopulation dynamics following a primary bovine herpesvirus-1 infection. Viral Immunology 1:267–286
    [Google Scholar]
15. Homan E. J., Easterday B. C. 1983; Experimental latent and recrudescent bovine herpesvirus-1 infections in calves. American Journal of Veterinary Research 44:309–313
    [Google Scholar]
16. Karupiah G., Blanden R. V., Ramshaw I. A. 1990; Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. Journal of Experimental Medicine 172:1495–1503
    [Google Scholar]
17. Kohonen-Corish M. R., King N. J., Woodhams C. E., Ramshaw I. A. 1990; Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. European Journal of Immunology 20:157–161
    [Google Scholar]
18. Kurzrock R., Rosenblum M. J., Sherwin S. A., Rios A., Talpaz M., Quesada J. R., Guttman J. U. 1985; Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients. Cancer Research 45:2866–2872
    [Google Scholar]
19. Leong K. H., Ramsay A. J., Boyle D. B., Ramshaw I. A. 1994; Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. Journal of Virology 68:8125–8130
    [Google Scholar]
20. Liang X. P., Babiuk L. A., van Drunen Littel-van den Hurk S., Fitzpatrick D. R., Zamb T. J. 1991a; Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. Journal of Virology 65:1124–1132
    [Google Scholar]
21. Liang X. P., Babiuk L. A., Zamb T. J. 1991b; Pseudorabies virus gIII and bovine herpesvirus 1 gIII share complementary functions. Journal of Virology 65:5553–5557
    [Google Scholar]
22. Liang X., Babiuk L. A., Zamb T. J. 1992; An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology 189:629–639
    [Google Scholar]
23. Muller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M., Aguet M. 1994; Functional role of type I and type II interferons in antiviral defence. Science 264:1918–1921
    [Google Scholar]
24. Raggo C., Fitzpatrick D. R., Babiuk L. A., Liang X. 1996; Expression of bovine interleukin-1 beta in a bovine herpesvirus-1 vector: in vitro analysis. Virology 221:78–86
    [Google Scholar]
25. Roth J. A., Frank D. E. 1989; Recombinant bovine interferon-gamma as an immunomodulator in dexamethasone-treated and nontreated cattle. Journal of Interferon Research 9:143–151
    [Google Scholar]
26. Sambhi S. K., Kohonen-Corish M. R., Ramshaw I. A. 1991; Local production of tumour necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proceedings of the National Academy of Sciences, USA 88:4025–4029
    [Google Scholar]
27. Straub C., Ahl R. 1976; Local interferon production in cattle after intranasal infection with avirulent IBR/IPV virus and its effect on a subsequent infection with foot-and-mouth disease virus. Zentralblatt fuer Veterinaermedizin Beiheft/Reihe B 23:470–482
    [Google Scholar]
28. van Drunen Littel-van den Hurk S., van den Hurk J. V., Gilchrist J. E., Misra V., Babiuk L. A. 1984; Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties. Virology 135:466–479
    [Google Scholar]
29. van Drunen Littel-van den Hurk S., Tikoo S. K., Liang X., Babiuk L. A. 1993; Bovine herpesvirus-1 vaccines. Immunology and Cell Biology 71:405–420
    [Google Scholar]
30. van Oirschot J. T., Kaashoek M. J., Rijsewijk F. A. 1996; Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Veterinary Microbiology 53:43–54
    [Google Scholar]
31. Wood G. S. 1990; The immunohistology of lymph nodes in HIV infection: a review. Progress in AIDS Pathology 2:25–32
    [Google Scholar]
32. Wyler R., Engels M., Schwyzer M. 1989; Infectious bovine rhinotracheitis/vulvovaginitis (BHV-1). In Herpesvirus Diseases of Cattle Horses and Pigs pp 1–72 Edited by Wittman G. Boston: Kluwer;
    [Google Scholar]
33. Yates W. D. 1982; A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral–bacterial synergism in respiratory disease of cattle. Canadian Journal of Comparative Medicine 46:225–263
    [Google Scholar]